Evidence map›Paper›PMID 34251066›Full record

ArticleJournal of clinical laboratory analysis2021

Correlation analysis of long non-coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph

Pengyun Zeng, Ye Chai, Chongge You, Lingling Yue, Chongyang Wu, Huiling Chen, Liangliang Li, Jingjing Li, Huan Liu, Yurong Zhang and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical laboratory analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Pengyun ZengDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Ye ChaiDepartment of Clinical Laboratory, Lanzhou University, Second Hospital, Lanzhou, China.
Chongge YouDepartment of Clinical Laboratory, Lanzhou University, Second Hospital, Lanzhou, China.ORCID https://orcid.org/0000-0001-8148-9335
Lingling YueDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Chongyang WuDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Huiling ChenDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Liangliang LiDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Jingjing LiDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Huan LiuDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Yurong ZhangDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Tingyong CaoDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Yaru LiDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Wanli HuDepartment of Hematology, Lanzhou University, Second Hospital, Lanzhou, China.
Lanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong non-coding RNA taurine-upregulated gene 1 (lncRNA TUG1) is reported to be involved in the progression and development of several malignancies; however, its role in Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph

methodsTotal 101 adult Ph

resultsLncRNA TUG1 was upregulated in Ph

conclusionlncRNA TUG1 presents potential to be a novel biomarker for disease risk assessment and survival surveillance in Ph

Indexed as

AdultBiomarkers, TumorCase-Control StudiesDisease-Free SurvivalFemaleGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeMalePrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisRetrospective StudiesRNA, Long NoncodingTreatment OutcomeBiomarkers, TumorRNA, Long NoncodingTUG1 long noncoding RNA, humanlong non-coding RNA TUG1Philadelphia chromosome-negative acute lymphoblastic leukemiareverse transcription-quantitative polymerase chain reactionsurvivaltreatment response

Identifiers

PMID34251066
PMCPMC8373340
OpenAlexW3179931215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.